{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T12:40:36Z","timestamp":1793364036441,"version":"4.5.0"},"reference-count":105,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,12,15]],"date-time":"2023-12-15T00:00:00Z","timestamp":1702598400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,12,15]],"date-time":"2023-12-15T00:00:00Z","timestamp":1702598400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Psychiatry"],"published-print":{"date-parts":[[2024,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Understanding the role of small, soluble aggregates of beta-amyloid (A\u03b2) and tau in Alzheimer\u2019s disease (AD) is of great importance for the rational design of preventative therapies. Here we report a set of methods for the detection, quantification, and characterisation of soluble aggregates in conditioned media of cerebral organoids derived from human iPSCs with trisomy 21, thus containing an extra copy of the amyloid precursor protein (APP) gene. We detected soluble beta-amyloid (A\u03b2) and tau aggregates secreted by cerebral organoids from both control and the isogenic trisomy 21 (T21) genotype. We developed a novel method to normalise measurements to the number of live neurons within organoid-conditioned media based on glucose consumption. Thus normalised, T21 organoids produced 2.5-fold more A\u03b2 aggregates with a higher proportion of larger (300\u20132000\u2009nm<jats:sup>2<\/jats:sup>) and more fibrillary-shaped aggregates than controls, along with 1.3-fold more soluble phosphorylated tau (pTau) aggregates, increased inflammasome ASC-specks, and a higher level of oxidative stress inducing thioredoxin-interacting protein (TXNIP). Importantly, all this was detectable prior to the appearance of histological amyloid plaques or intraneuronal tau-pathology in organoid slices, demonstrating the feasibility to model the initial pathogenic mechanisms for AD in-vitro using cells from live genetically pre-disposed donors before the onset of clinical disease. Then, using different iPSC clones generated from the same donor at different times in two independent experiments, we tested the reproducibility of findings in organoids. While there were differences in rates of disease progression between the experiments, the disease mechanisms were conserved. Overall, our results show that it is possible to non-invasively follow the development of pathology in organoid models of AD over time, by monitoring changes in the aggregates and proteins in the conditioned media, and open possibilities to study the time-course of the key pathogenic processes taking place.<\/jats:p>","DOI":"10.1038\/s41380-023-02333-3","type":"journal-article","created":{"date-parts":[[2023,12,15]],"date-time":"2023-12-15T08:02:16Z","timestamp":1702627336000},"page":"369-386","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Cerebral organoids with chromosome 21 trisomy secrete Alzheimer\u2019s disease-related soluble aggregates detectable by single-molecule-fluorescence and super-resolution microscopy"],"prefix":"10.1038","volume":"29","author":[{"given":"Emre","family":"Fertan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorothea","family":"B\u00f6ken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4780-3957","authenticated-orcid":false,"given":"Aoife","family":"Murray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John S. H.","family":"Danial","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeff Y. L.","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunzhao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pollyanna A.","family":"Goh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8125-8198","authenticated-orcid":false,"given":"Ivan","family":"Ali\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew R.","family":"Cheetham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evgeniia","family":"Lobanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu P.","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5486-5761","authenticated-orcid":false,"given":"Dean","family":"Ni\u017eeti\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7116-6954","authenticated-orcid":false,"given":"David","family":"Klenerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,15]]},"reference":[{"key":"2333_CR1","doi-asserted-by":"crossref","unstructured":"Scheltens P, de Strooper B, Kivipelto M, Holstege H, Ch\u00e9telat G, Teunissen CE, et al. Alzheimer\u2019s disease. Lancet [Internet]. 2021; Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0140673620322054.","DOI":"10.1016\/S0140-6736(20)32205-4"},{"key":"2333_CR2","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1212\/01.wnl.0000344568.09360.31","volume":"72","author":"WJP Henneman","year":"2009","unstructured":"Henneman WJP, Sluimer JD, Barnes J, van der Flier WM, Sluimer IC, Fox NC. et al. Hippocampal atrophy rates in Alzheimer disease: added value over whole brain volume measures. Neurologia [Internet].2009;72:999\u20131007. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19289740.","journal-title":"Neurologia [Internet]."},{"key":"2333_CR3","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1002\/ana.410300410","volume":"30","author":"RD Terry","year":"1991","unstructured":"Terry RD, Masliah E, Salmon DP, Butters N, DeTeresa R, Hill R. et al. Physical basis of cognitive alterations in Alzheimer\u2019s disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol [Internet].1991;30:572\u201380. https:\/\/pubmed.ncbi.nlm.nih.gov\/1789684\/.","journal-title":"Ann Neurol [Internet]."},{"key":"2333_CR4","doi-asserted-by":"publisher","first-page":"e0151710","DOI":"10.1371\/journal.pone.0151710","volume":"11","author":"I Cova","year":"2016","unstructured":"Cova I, Clerici F, Rossi A, Cucumo V, Ghiretti R, Maggiore L. et al. Weight loss predicts progression of mild cognitive impairment to Alzheimer\u2019s disease. PLoS One [Internet].2016;11:e0151710 http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26990757.","journal-title":"PLoS One [Internet]."},{"key":"2333_CR5","doi-asserted-by":"publisher","first-page":"712","DOI":"10.2174\/1567205012666150701103107","volume":"12","author":"J Raskin","year":"2015","unstructured":"Raskin J, Cummings J, Hardy J, Schuh K, Dean RA. Neurobiology of Alzheimer\u2019s disease: integrated molecular, physiological, anatomical, biomarker, and cognitive dimensions. Curr Alzheimer Res [Internet].2015;12:712\u201322. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26412218.","journal-title":"Curr Alzheimer Res [Internet]."},{"key":"2333_CR6","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.nrl.2016.02.016","volume":"32","author":"H Niu","year":"2017","unstructured":"Niu H, \u00c1lvarez-\u00c1lvarez I, Guill\u00e9n-Grima F, Aguinaga-Ontoso I. Prevalence and incidence of Alzheimer\u2019s disease in Europe: a meta-analysis. Neurologia [Internet].2017;32:523\u201332. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26412218.","journal-title":"Neurologia [Internet]."},{"key":"2333_CR7","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1002\/ca.980080612","volume":"8","author":"RA Stelzmann","year":"1995","unstructured":"Stelzmann RA, Norman Schnitzlein H, Reed Murtagh F, Murtagh FR. An English translation of Alzheimer\u2019s 1907 paper, \u201cUber eine eigenartige erkankung der hirnrinde\u201d. Clin Anat [Internet].1995;8:429\u201331. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8713166.","journal-title":"Clin Anat [Internet]."},{"key":"2333_CR8","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/S0006-291X(84)80190-4","volume":"120","author":"GG Glenner","year":"1984","unstructured":"Glenner GG, Wong CW. Alzheimer\u2019s disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun [Internet].1984;120:885\u201390. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/6375662.","journal-title":"Biochem Biophys Res Commun [Internet]."},{"key":"2333_CR9","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1126\/science.1566067","volume":"256","author":"JA Hardy","year":"1992","unstructured":"Hardy JA, Higgins GA. Alzheimer\u2019s disease: the amyloid cascade hypothesis. Science [Internet].1992;256:184\u20135. https:\/\/pubmed.ncbi.nlm.nih.gov\/1566067\/.","journal-title":"Science [Internet]."},{"key":"2333_CR10","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/0165-6147(91)90609-V","volume":"12","author":"J Hardy","year":"1991","unstructured":"Hardy J, Allsop D. Amyloid deposition as the central event in the aetiology of Alzheimer\u2019s disease. Trends Pharm Sci [Internet].1991;12:383\u20138. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/1763432.","journal-title":"Trends Pharm Sci [Internet]."},{"key":"2333_CR11","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/scientificamerican1191-68","volume":"265","author":"DJ Selkoe","year":"1991","unstructured":"Selkoe DJ. Amyloid protein and Alzheimer\u2019s disease. Sci Am [Internet].1991;265:68\u201371. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/1785042.","journal-title":"Sci Am [Internet]."},{"key":"2333_CR12","first-page":"135","volume":"2","author":"GP Morris","year":"2014","unstructured":"Morris GP, Clark IA, Vissel B. Inconsistencies and controversies surrounding the amyloid hypothesis of Alzheimer\u2019s disease. Acta Neuropathol Commun [Internet].2014;2:135 http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25231068.","journal-title":"Acta Neuropathol Commun [Internet]."},{"key":"2333_CR13","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1212\/WNL.46.3.707","volume":"46","author":"JC Morris","year":"1996","unstructured":"Morris JC, Storandt M, McKeel DW, Rubin EH, Price JL, Grant EA. et al. Cerebral amyloid deposition and diffuse plaques in \u201cnormal\u201d aging: evidence for presymptomatic and very mild Alzheimer\u2019s disease. Neurologia [Internet].1996;46:707\u201319. https:\/\/pubmed.ncbi.nlm.nih.gov\/8618671\/.","journal-title":"Neurologia [Internet]."},{"key":"2333_CR14","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1111\/jgs.15830","volume":"67","author":"YM Huang","year":"2019","unstructured":"Huang YM, Shen J, Zhao HL. Major clinical trials failed the amyloid hypothesis of Alzheimer\u2019s disease. J Am Geriatr Soc [Internet].2019;67:841\u20134. https:\/\/pubmed.ncbi.nlm.nih.gov\/30851121\/.","journal-title":"J Am Geriatr Soc [Internet]."},{"key":"2333_CR15","doi-asserted-by":"crossref","unstructured":"Asher S, Priefer R. Alzheimer\u2019s disease failed clinical trials. Life Sci [Internet]. 2022;306. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/35932841\/.","DOI":"10.1016\/j.lfs.2022.120861"},{"key":"2333_CR16","doi-asserted-by":"crossref","unstructured":"Mullane K, Williams M. Alzheimer\u2019s disease beyond amyloid: can the repetitive failures of amyloid-targeted therapeutics inform future approaches to dementia drug discovery? Biochem Pharmacol [Internet]. 2020;177. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/32247851\/.","DOI":"10.1016\/j.bcp.2020.113945"},{"key":"2333_CR17","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/nrn3880","volume":"16","author":"FL Heppner","year":"2015","unstructured":"Heppner FL, Ransohoff RM, Becher B. Immune attack: the role of inflammation in Alzheimer\u2019s disease. Nat Rev Neurosci [Internet]. 2015;16:358\u201372. https:\/\/doi.org\/10.1038\/nrn3880.","journal-title":"Nat Rev Neurosci [Internet]"},{"key":"2333_CR18","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1007\/s10571-017-0574-1","volume":"38","author":"FP Chong","year":"2018","unstructured":"Chong FP, Ng KY, Koh RY, Chye SM. Tau proteins and tauopathies in Alzheimer\u2019s disease. Cell Mol Neurobiol [Internet]. 2018;38:965\u201380. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/29299792.","journal-title":"Cell Mol Neurobiol [Internet]"},{"key":"2333_CR19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/alzrt231","volume":"6","author":"WF Goure","year":"2014","unstructured":"Goure WF, Krafft GA, Jerecic J, Hefti F. Targeting the proper amyloid-beta neuronal toxins: a path forward for Alzheimer\u2019s disease immunotherapeutics. Alzheimers Res Ther [Internet]. 2014;6:1\u201315. https:\/\/alzres.biomedcentral.com\/articles\/10.1186\/alzrt272.","journal-title":"Alzheimers Res Ther [Internet]"},{"key":"2333_CR20","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/nn.3028","volume":"15","author":"I Benilova","year":"2012","unstructured":"Benilova I, Karran E, de Strooper B. The toxic A\u03b2 oligomer and Alzheimer\u2019s disease: an emperor in need of clothes. Nat Neurosci. 2012;15:349\u201357. https:\/\/www.nature.com\/articles\/nn.3028 cited 9 Jan 2023.","journal-title":"Nat Neurosci"},{"key":"2333_CR21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s42003-019-0734-6","volume":"3","author":"C Hughes","year":"2020","unstructured":"Hughes C, Choi ML, Yi JH, Kim SC, Drews A, George-Hyslop PS. et al. Beta amyloid aggregates induce sensitised TLR4 signalling causing long-term potentiation deficit and rat neuronal cell death. Commun Biol [Internet].2020;3:1\u20137. https:\/\/www.nature.com\/articles\/s42003-020-0792-9.","journal-title":"Commun Biol [Internet]."},{"key":"2333_CR22","doi-asserted-by":"publisher","first-page":"701","DOI":"10.3233\/JAD-2011-110890","volume":"27","author":"A Lloret","year":"2011","unstructured":"Lloret A, Badia MC, Giraldo E, Ermak G, Alonso MD, Pallard\u00f3 FV. et al. Amyloid-\u03b2 toxicity and tau hyperphosphorylation are linked via RCAN1 in Alzheimer\u2019s disease. J Alzheimers Dis [Internet].2011;27:701\u20139. https:\/\/pubmed.ncbi.nlm.nih.gov\/21876249\/.","journal-title":"J Alzheimers Dis [Internet]."},{"key":"2333_CR23","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1001\/jamaneurol.2013.5847","volume":"71","author":"GS Bloom","year":"2014","unstructured":"Bloom GS. Amyloid-\u03b2 and tau: the trigger and bullet in Alzheimer disease pathogenesis. JAMA Neurol [Internet]. 2014;71:505\u20138. https:\/\/pubmed.ncbi.nlm.nih.gov\/24493463\/.","journal-title":"JAMA Neurol [Internet]"},{"key":"2333_CR24","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1038\/s41598-023-29248-x","volume":"13","author":"E Fertan","year":"2023","unstructured":"Fertan E, Gendron WH, Wong AA, Hanson GM, Brown RE, Weaver ICG. Noncanonical regulation of imprinted gene Igf2 by amyloid-beta 1-42 in Alzheimer\u2019s disease. Sci Rep. [Internet]. 2023;13:2043 https:\/\/pubmed.ncbi.nlm.nih.gov\/36739453\/.","journal-title":"Sci Rep. [Internet]"},{"key":"2333_CR25","doi-asserted-by":"publisher","first-page":"595","DOI":"10.15252\/emmm.201606210","volume":"8","author":"DJ Selkoe","year":"2016","unstructured":"Selkoe DJ, Hardy J. The amyloid hypothesis of Alzheimer\u2019s disease at 25 years. EMBO Mol Med [Internet]. 2016;8:595\u2013608. https:\/\/doi.org\/10.15252\/emmm.201606210.","journal-title":"EMBO Mol Med [Internet]"},{"key":"2333_CR26","first-page":"259","volume":"3","author":"LJH Down","year":"1866","unstructured":"Down LJH. Observations on an ethnic classification of idiots. Lond Hosp Rep. 1866;3:259\u201362.","journal-title":"Lond Hosp Rep"},{"key":"2333_CR27","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1002\/mrdd.20157","volume":"13","author":"SL Sherman","year":"2007","unstructured":"Sherman SL, Allen EG, Bean LH, Freeman SB. Epidemiology of Down syndrome. Ment Retard Dev Disabil Res Rev [Internet]. 2007;13:221\u20137. https:\/\/pubmed.ncbi.nlm.nih.gov\/17910090\/.","journal-title":"Ment Retard Dev Disabil Res Rev [Internet]"},{"key":"2333_CR28","doi-asserted-by":"crossref","unstructured":"Antonarakis SE, Skotko BG, Rafii MS, Strydom A, Pape SE, Bianchi DW, et al. Down syndrome. Nat Rev Dis Primers. 2020;6:9. https:\/\/pubmed.ncbi.nlm.nih.gov\/32029743\/.","DOI":"10.1038\/s41572-019-0143-7"},{"key":"2333_CR29","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/B978-0-12-804766-8.00017-0","volume":"167","author":"MS Rafii","year":"2019","unstructured":"Rafii MS, Kleschevnikov AM, Sawa M, Mobley WC. Down syndrome. Handb Clin Neurol [Internet]. 2019;167:321\u201336. https:\/\/pubmed.ncbi.nlm.nih.gov\/31753140\/.","journal-title":"Handb Clin Neurol [Internet]"},{"key":"2333_CR30","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1097\/YPG.0b013e32835fe426","volume":"23","author":"S Vicari","year":"2013","unstructured":"Vicari S, Pontillo M, Armando M. Neurodevelopmental and psychiatric issues in Down\u2019s syndrome: assessment and intervention. Psychiatr Genet [Internet]. 2013;23:95\u2013107. https:\/\/pubmed.ncbi.nlm.nih.gov\/23492931\/.","journal-title":"Psychiatr Genet [Internet]"},{"key":"2333_CR31","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.12659\/MSM.893377","volume":"21","author":"R Malak","year":"2015","unstructured":"Malak R, Kostiukow A, Krawczyk-Wasielewska A, Mojs E, Samborski W. Delays in motor development in children with Down syndrome. Med Sci Monit [Internet]. 2015;21:1904\u201310. https:\/\/pubmed.ncbi.nlm.nih.gov\/26132100\/.","journal-title":"Med Sci Monit [Internet]"},{"key":"2333_CR32","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1002\/ajmg.c.31439","volume":"169","author":"J Grieco","year":"2015","unstructured":"Grieco J, Pulsifer M, Seligsohn K, Skotko B, Schwartz A. Down syndrome: cognitive and behavioral functioning across the lifespan. Am J Med Genet C Semin Med Genet [Internet]. 2015;169:135\u201349. https:\/\/pubmed.ncbi.nlm.nih.gov\/25989505\/.","journal-title":"Am J Med Genet C Semin Med Genet [Internet]"},{"key":"2333_CR33","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/S1474-4422(10)70112-5","volume":"9","author":"IT Lott","year":"2010","unstructured":"Lott IT, Dierssen M. Cognitive deficits and associated neurological complications in individuals with Down\u2019s syndrome. Lancet Neurol [Internet]. 2010;9:623\u201333. https:\/\/pubmed.ncbi.nlm.nih.gov\/20494326\/.","journal-title":"Lancet Neurol [Internet]"},{"key":"2333_CR34","unstructured":"Johnson RC, Abelson RB. Intellectual, behavioral, and physical characteristics associated with trisomy, translocation, and mosaic types of Down\u2019s syndrome. Am J Ment Defic. 1969;73:852\u20135."},{"key":"2333_CR35","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1002\/ajmg.a.36861","volume":"167A","author":"P Papavassiliou","year":"2015","unstructured":"Papavassiliou P, Charalsawadi C, Rafferty K, Jackson-Cook C. Mosaicism for trisomy 21: a review. Am J Med Genet A [Internet]. 2015;167A:26\u201339. https:\/\/pubmed.ncbi.nlm.nih.gov\/25412855\/.","journal-title":"Am J Med Genet A [Internet]"},{"key":"2333_CR36","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1192\/bjp.95.400.685","volume":"95","author":"LS Penrose","year":"1949","unstructured":"Penrose LS. The incidence of mongolism in the general population. J Ment Sci [Internet]. 1949;95:685\u20138. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18148788.","journal-title":"J Ment Sci [Internet]"},{"key":"2333_CR37","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1038\/ejhg.2012.294","volume":"21","author":"J Wu","year":"2013","unstructured":"Wu J, Morris JK. The population prevalence of Down\u2019s syndrome in England and Wales in 2011. Eur J Hum Genet [Internet]. 2013;21:1016\u20139. https:\/\/pubmed.ncbi.nlm.nih.gov\/23321618\/.","journal-title":"Eur J Hum Genet [Internet]"},{"key":"2333_CR38","first-page":"353","volume":"1","author":"E Head","year":"2012","unstructured":"Head E, Powell D, Gold BT, Schmitt FA. Alzheimer\u2019s disease in Down syndrome. Eur J Neurodegener Dis [Internet]. 2012;1:353.","journal-title":"Eur J Neurodegener Dis [Internet]"},{"key":"2333_CR39","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/S1474-4422(21)00245-3","volume":"20","author":"J Fortea","year":"2021","unstructured":"Fortea J, Zaman SH, Hartley S, Rafii MS, Head E, Carmona-Iragui M. Alzheimer\u2019s disease associated with Down syndrome: a genetic form of dementia. Lancet Neurol [Internet]. 2021;20:930\u201342. https:\/\/pubmed.ncbi.nlm.nih.gov\/34687637\/.","journal-title":"Lancet Neurol [Internet]"},{"key":"2333_CR40","doi-asserted-by":"publisher","first-page":"459","DOI":"10.3233\/JAD-160836","volume":"56","author":"E Doran","year":"2017","unstructured":"Doran E, Keator D, Head E, Phelan MJ, Kim R, Totoiu M, et al. Down syndrome, partial trisomy 21, and absence of Alzheimer\u2019s disease: the role of APP. J Alzheimers Dis [Internet] 2017;56:459.","journal-title":"J Alzheimers Dis [Internet]"},{"key":"2333_CR41","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1002\/ana.410430316","volume":"43","author":"VP Prasher","year":"1998","unstructured":"Prasher VP, Farrer MJ, Kessling AM, Fisher EMCC, West RJ, Barber PC. et al. Molecular mapping of Alzheimer-type dementia in Down\u2019s syndrome. Ann Neurol [Internet]. 1998;43:380\u20133. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9506555.","journal-title":"Ann Neurol [Internet]"},{"key":"2333_CR42","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/ng1718","volume":"38","author":"A Rovelet-Lecrux","year":"2006","unstructured":"Rovelet-Lecrux A, Hannequin D, Raux G, Meur N, le, Laquerri\u00e8re A, Vital A. et al. APP locus duplication causes autosomal dominant early-onset Alzheimer\u2019s disease with cerebral amyloid angiopathy. Nat Genet [Internet].2006;38:24\u20136. https:\/\/pubmed.ncbi.nlm.nih.gov\/16369530\/.","journal-title":"Nat Genet [Internet]."},{"key":"2333_CR43","doi-asserted-by":"publisher","first-page":"5766","DOI":"10.1038\/s41380-020-0806-5","volume":"26","author":"I Ali\u0107","year":"2021","unstructured":"Ali\u0107 I, Goh PA, Murray A, Portelius E, Gkanatsiou E, Gough G. et al. Patient-specific Alzheimer-like pathology in trisomy 21 cerebral organoids reveals BACE2 as a gene dose-sensitive AD suppressor in human brain. Mol Psychiatry [Internet].2021;26:5766\u201388. https:\/\/pubmed.ncbi.nlm.nih.gov\/32647257\/.","journal-title":"Mol Psychiatry [Internet]."},{"key":"2333_CR44","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1177\/0963689717752946","volume":"27","author":"AM Yakoub","year":"2018","unstructured":"Yakoub AM, Sadek M. Development and characterization of human cerebral organoids: an optimized protocol. Cell Transpl [Internet]. 2018;27:393.","journal-title":"Cell Transpl [Internet]."},{"key":"2333_CR45","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/s41586-019-1289-x","volume":"570","author":"S Velasco","year":"2019","unstructured":"Velasco S, Kedaigle AJ, Simmons SK, Nash A, Rocha M, Quadrato G. et al. Individual brain organoids reproducibly form cell diversity of the human cerebral cortex. Nature [Internet].2019;570:523\u20137. https:\/\/pubmed.ncbi.nlm.nih.gov\/31168097\/.","journal-title":"Nature [Internet]."},{"key":"2333_CR46","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1021\/ja3103567","volume":"135","author":"P Narayan","year":"2013","unstructured":"Narayan P, Ganzinger KA, McColl J, Weimann L, Meehan S, Qamar S. et al. Single molecule characterization of the interactions between amyloid-\u03b2 peptides and the membranes of hippocampal cells. J Am Chem Soc [Internet].2013;135:1491\u20138. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23339742.","journal-title":"J Am Chem Soc [Internet]."},{"key":"2333_CR47","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1021\/acschemneuro.5b00324","volume":"7","author":"MH Horrocks","year":"2016","unstructured":"Horrocks MH, Lee SF, Gandhi S, Magdalinou NK, Chen SW, Devine MJ, et al. Single-molecule imaging of individual amyloid protein aggregates in human biofluids. ACS Chem Neurosci [Internet]. 2016;7:399\u2013406.","journal-title":"ACS Chem Neurosci [Internet]."},{"key":"2333_CR48","doi-asserted-by":"crossref","unstructured":"Sideris DI, Danial JSH, Emin D, Ruggeri FS, Xia Z, Zhang YP, et al. Soluble amyloid beta-containing aggregates are present throughout the brain at early stages of Alzheimer\u2019s disease. Brain Commun [Internet]. 2021;3. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/34396107\/.","DOI":"10.1093\/braincomms\/fcab147"},{"key":"2333_CR49","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.1002\/cbic.201800209","volume":"19","author":"DR Whiten","year":"2018","unstructured":"Whiten DR, Zuo Y, Calo L, Choi ML, De S, Flagmeier P. et al. Nanoscopic characterisation of individual Endogenous protein aggregates in human neuronal cells. ChemBioChem [Internet].2018;19:2033\u20138. https:\/\/pubmed.ncbi.nlm.nih.gov\/30051958\/.","journal-title":"ChemBioChem [Internet]."},{"key":"2333_CR50","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/s40478-019-0777-4","volume":"7","author":"S De","year":"2019","unstructured":"De S, Whiten DR, Ruggeri FS, Hughes C, Rodrigues M, Sideris DI. et al. Soluble aggregates present in cerebrospinal fluid change in size and mechanism of toxicity during Alzheimer\u2019s disease progression. Acta Neuropathol Commun [Internet].2019;7:120 https:\/\/actaneurocomms.biomedcentral.com\/articles\/10.1186\/s40478-019-0777-4.","journal-title":"Acta Neuropathol Commun [Internet]."},{"key":"2333_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-019-09477-3","volume":"10","author":"S De","year":"2019","unstructured":"De S, Wirthensohn DC, Flagmeier P, Hughes C, Aprile FA, Ruggeri FS, et al. Different soluble aggregates of A\u03b242 can give rise to cellular toxicity through different mechanisms. Nat Commun [Internet]. 2019;10:1\u201311. https:\/\/doi.org\/10.1038\/s41467-019-09477-3.","journal-title":"Nat Commun [Internet]."},{"key":"2333_CR52","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1002\/stem.1968","volume":"33","author":"A Murray","year":"2015","unstructured":"Murray A, Letourneau A, Canzonetta C, Stathaki E, Gimelli S, Sloan-Bena F. et al. Brief report: isogenic induced pluripotent stem cell lines from an adult with mosaic down syndrome model accelerated neuronal ageing and neurodegeneration. Stem Cells [Internet].2015;33:2077\u201384. https:\/\/pubmed.ncbi.nlm.nih.gov\/25694335\/.","journal-title":"Stem Cells [Internet]."},{"key":"2333_CR53","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1038\/nprot.2014.158","volume":"9","author":"MA Lancaster","year":"2014","unstructured":"Lancaster MA, Knoblich JA. Generation of cerebral organoids from human pluripotent stem cells. Nat Protoc [Internet].2014;9:2329\u201340. https:\/\/pubmed.ncbi.nlm.nih.gov\/25188634\/.","journal-title":"Nat Protoc [Internet]."},{"key":"2333_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-022-33252-6","volume":"13","author":"D Emin","year":"2022","unstructured":"Emin D, Zhang YP, Lobanova E, Miller A, Li X, Xia Z. et al. Small soluble \u03b1-synuclein aggregates are the toxic species in Parkinson\u2019s disease. Nat Commun. 2022;13:1\u201315. https:\/\/www.nature.com\/articles\/s41467-022-33252-6.","journal-title":"Nat Commun"},{"key":"2333_CR55","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1038\/s41557-020-0506-4","volume":"12","author":"M di Antonio","year":"2020","unstructured":"di Antonio M, Ponjavic A, Radzevi\u010dius A, Ranasinghe RT, Catalano M, Zhang X. et al. Single-molecule visualization of DNA G-quadruplex formation in live cells. Nat Chem [Internet].2020;12:832\u20137. https:\/\/pubmed.ncbi.nlm.nih.gov\/32690897\/.","journal-title":"Nat Chem [Internet]."},{"key":"2333_CR56","doi-asserted-by":"publisher","first-page":"2570","DOI":"10.1038\/s41596-022-00730-6","volume":"17","author":"JSH Danial","year":"2022","unstructured":"Danial JSH, Lam JYL, Wu Y, Woolley M, Dimou E, Cheetham MR. et al. Constructing a cost-efficient, high-throughput and high-quality single-molecule localization microscope for super-resolution imaging. Nat Protoc [Internet].2022;17:2570\u2013619. https:\/\/pubmed.ncbi.nlm.nih.gov\/36002768\/.","journal-title":"Nat Protoc [Internet]."},{"key":"2333_CR57","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1038\/nprot.2017.024","volume":"12","author":"J Schnitzbauer","year":"2017","unstructured":"Schnitzbauer J, Strauss MT, Schlichthaerle T, Schueder F, Jungmann R. Super-resolution microscopy with DNA-PAINT. Nat Protoc [Internet].2017;12:1198\u2013228. https:\/\/www.nature.com\/articles\/nprot.2017.024.","journal-title":"Nat Protoc [Internet]."},{"key":"2333_CR58","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1038\/s41592-020-0869-x","volume":"17","author":"S Strauss","year":"2020","unstructured":"Strauss S, Jungmann R. Up to 100-fold speed-up and multiplexing in optimized DNA-PAINT. Nat Methods [Internet]. 2020;17:789\u201391. https:\/\/doi.org\/10.1038\/s41592-020-0869-x.","journal-title":"Nat Methods [Internet]."},{"key":"2333_CR59","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.ymeth.2019.05.008","volume":"174","author":"A Jimenez","year":"2020","unstructured":"Jimenez A, Friedl K, Leterrier C. About samples, giving examples: optimized single molecule localization microscopy. Methods. 2020;174:100\u201314.","journal-title":"Methods."},{"key":"2333_CR60","doi-asserted-by":"publisher","first-page":"100499","DOI":"10.1016\/j.crmeth.2023.100499","volume":"3","author":"Z Xia","year":"2023","unstructured":"Xia Z, Wu Y, Lam JYL, Zhang Z, Burke M, Fertan E. et al. A computational suite for the structural and functional characterization of amyloid aggregates. Cell Rep Methods [Internet].2023;3:100499 https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667237523001285.","journal-title":"Cell Rep Methods [Internet]."},{"key":"2333_CR61","doi-asserted-by":"publisher","first-page":"13044","DOI":"10.1021\/acs.analchem.7b04335","volume":"89","author":"G Je","year":"2017","unstructured":"Je G, Croop B, Basu S, Tang J, Han KY, Kim YS. Endogenous alpha-synuclein protein analysis from human brain tissues using single-molecule pull-down assay. Anal Chem [Internet].2017;89:13044\u20138. https:\/\/pubmed.ncbi.nlm.nih.gov\/29172450\/.","journal-title":"Anal Chem [Internet]."},{"key":"2333_CR62","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/978-1-62703-523-1_8","volume":"1040","author":"A Stutz","year":"2013","unstructured":"Stutz A, Horvath GL, Monks BG, Latz E. ASC speck formation as a readout for inflammasome activation. Methods Mol Biol [Internet].2013;1040:91\u2013101. https:\/\/pubmed.ncbi.nlm.nih.gov\/23852599\/.","journal-title":"Methods Mol Biol [Internet]."},{"key":"2333_CR63","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1177\/2211068215589580","volume":"21","author":"DH Wilson","year":"2016","unstructured":"Wilson DH, Rissin DM, Kan CW, Fournier DR, Piech T, Campbell TG. et al. The simoa HD-1 analyzer: a novel fully automated digital immunoassay analyzer with single-molecule sensitivity and multiplexing. J Lab Autom [Internet].2016;21:533\u201347. https:\/\/pubmed.ncbi.nlm.nih.gov\/26077162\/.","journal-title":"J Lab Autom [Internet]."},{"key":"2333_CR64","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/s41386-020-00840-3","volume":"46","author":"S Rayaprolu","year":"2021","unstructured":"Rayaprolu S, Higginbotham L, Bagchi P, Watson CM, Zhang T, Levey AI, et al. Systems-based proteomics to resolve the biology of Alzheimer\u2019s disease beyond amyloid and tau. Neuropsychopharmacology [Internet]. 2021;46:98.","journal-title":"Neuropsychopharmacology [Internet]."},{"key":"2333_CR65","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1038\/s41380-018-0229-8","volume":"23","author":"C Gonzalez","year":"2018","unstructured":"Gonzalez C, Armijo E, Bravo-Alegria J, Becerra-Calixto A, Mays CE, Soto C. Modeling amyloid beta and tau pathology in human cerebral organoids. Mol Psychiatry [Internet].2018;23:2363\u201374. https:\/\/pubmed.ncbi.nlm.nih.gov\/30171212\/.","journal-title":"Mol Psychiatry [Internet]."},{"key":"2333_CR66","doi-asserted-by":"crossref","unstructured":"Zhao HH, Haddad GG. Alzheimer\u2019s disease like neuropathology in Down syndrome cortical organoids. Front Cell Neurosci [Internet]. 2022;16. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/36568886\/.","DOI":"10.3389\/fncel.2022.1050432"},{"key":"2333_CR67","doi-asserted-by":"crossref","unstructured":"Czerminski JT, King OD, Lawrence JB. Large-scale organoid study suggests effects of trisomy 21 on early fetal neurodevelopment are more subtle than variability between isogenic lines and experiments. Front Neurosci [Internet]. 2023;16. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/36817096\/.","DOI":"10.3389\/fnins.2022.972201"},{"key":"2333_CR68","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1038\/ncb1807","volume":"10","author":"AE Vaughn","year":"2008","unstructured":"Vaughn AE, Deshmukh M. Glucose metabolism inhibits apoptosis in neurons and cancer cells by redox inactivation of cytochrome c. Nat Cell Biol [Internet]. 2008;10:1477.","journal-title":"Nat Cell Biol [Internet]."},{"key":"2333_CR69","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.tins.2013.07.001","volume":"36","author":"P Mergenthaler","year":"2013","unstructured":"Mergenthaler P, Lindauer U, Dienel GA, Meisel A. Sugar for the brain: the role of glucose in physiological and pathological brain function. Trends Neurosci [Internet]. 2013;36:587.","journal-title":"Trends Neurosci [Internet]."},{"key":"2333_CR70","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.freeradbiomed.2017.09.013","volume":"114","author":"E Head","year":"2018","unstructured":"Head E, Helman AM, Powell D, Schmitt FA. Down syndrome, beta-amyloid and neuroimaging. Free Radic Biol Med [Internet].2018;114:102\u20139. https:\/\/pubmed.ncbi.nlm.nih.gov\/28935420\/.","journal-title":"Free Radic Biol Med [Internet]."},{"key":"2333_CR71","doi-asserted-by":"crossref","unstructured":"Zammit MD, Tudorascu DL, Laymon CM, Hartley SL, Zaman SH, Ances BM, et al. PET measurement of longitudinal amyloid load identifies the earliest stages of amyloid-beta accumulation during Alzheimer\u2019s disease progression in Down syndrome. Neuroimage [Internet]. 2021;228. https:\/\/pubmed.ncbi.nlm.nih.gov\/33421595\/.","DOI":"10.1016\/j.neuroimage.2021.117728"},{"key":"2333_CR72","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/j.jalz.2015.07.490","volume":"12","author":"T Annus","year":"2016","unstructured":"Annus T, Wilson LR, Hong YT, Acosta-Cabronero J, Fryer TD, Cardenas-Blanco A. et al. The pattern of amyloid accumulation in the brains of adults with Down syndrome. Alzheimer\u2019s Dement [Internet].2016;12:538\u201345. https:\/\/pubmed.ncbi.nlm.nih.gov\/26362596\/.","journal-title":"Alzheimer\u2019s Dement [Internet]."},{"key":"2333_CR73","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/nm0196-93","volume":"2","author":"JK Teller","year":"1996","unstructured":"Teller JK, Russo C, DeBusk LM, Angelini G, Zaccheo D, Dagna-Bricarelli F. et al. Presence of soluble amyloid beta-peptide precedes amyloid plaque formation in Down\u2019s syndrome. Nat Med [Internet].1996;2:93\u20135. https:\/\/pubmed.ncbi.nlm.nih.gov\/8564851\/.","journal-title":"Nat Med [Internet]."},{"key":"2333_CR74","doi-asserted-by":"publisher","first-page":"100988","DOI":"10.1016\/j.eclinm.2021.100988","volume":"38","author":"A Sturchio","year":"2021","unstructured":"Sturchio A, Dwivedi AK, Young CB, Malm T, Marsili L, Sharma JS. et al. High cerebrospinal amyloid-\u03b2 42 is associated with normal cognition in individuals with brain amyloidosis. EClinicalMedicine [Internet]. 2021;38:100988 http:\/\/www.thelancet.com\/article\/S2589537021002686\/fulltext.","journal-title":"EClinicalMedicine [Internet]"},{"key":"2333_CR75","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1093\/brain\/awv326","volume":"139","author":"W Jagust","year":"2016","unstructured":"Jagust W. Is amyloid-\u03b2 harmful to the brain? Insights from human imaging studies. Brain [Internet]. 2016;139:23.","journal-title":"Brain [Internet]."},{"key":"2333_CR76","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1212\/01.WNL.0000151958.79884.86","volume":"64","author":"T Katsuno","year":"2005","unstructured":"Katsuno T, Morishima-Kawashima M, Saito Y, Yamanouchi H, Ishiura S, Murayama S. et al. Independent accumulations of tau and amyloid beta-protein in the human entorhinal cortex. Neurologia [Internet].2005;64:687\u201392. https:\/\/pubmed.ncbi.nlm.nih.gov\/15728293\/.","journal-title":"Neurologia [Internet]."},{"key":"2333_CR77","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1001\/jamaneurol.2022.1740","volume":"79","author":"S Janelidze","year":"2022","unstructured":"Janelidze S, Christian BT, Price J, Laymon C, Schupf N, Klunk WE. et al. Detection of brain tau pathology in down syndrome using plasma biomarkers. JAMA Neurol [Internet]. 2022;79:797\u2013807. https:\/\/pubmed.ncbi.nlm.nih.gov\/35789365\/.","journal-title":"JAMA Neurol [Internet]"},{"key":"2333_CR78","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1002\/ana.26321","volume":"91","author":"ME Curtis","year":"2022","unstructured":"Curtis ME, Smith T, Yu D, Pratic\u00f2 D. Association of retromer deficiency and tau pathology in down syndrome. Ann Neurol [Internet].2022;91:561\u20137. https:\/\/pubmed.ncbi.nlm.nih.gov\/35150166\/.","journal-title":"Ann Neurol [Internet]."},{"key":"2333_CR79","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/s41586-019-1769-z","volume":"575","author":"C Ising","year":"2019","unstructured":"Ising C, Venegas C, Zhang S, Scheiblich H, Schmidt SV, Vieira-Saecker A. et al. NLRP3 inflammasome activation drives tau pathology. Nature. 2019;575:669\u201373. https:\/\/www.nature.com\/articles\/s41586-019-1769-z.","journal-title":"Nature"},{"key":"2333_CR80","doi-asserted-by":"publisher","first-page":"4586","DOI":"10.1111\/ejn.15016","volume":"52","author":"S Zhang","year":"2020","unstructured":"Zhang S, Zong Y, Ren Z, Hu J, Wu X, Xiao H. et al. Regulation of indoleamine 2, 3-dioxygenase in hippocampal microglia by NLRP3 inflammasome in lipopolysaccharide-induced depressive-like behaviors. Eur J Neurosci [Internet].2020;52:4586\u2013601. https:\/\/pubmed.ncbi.nlm.nih.gov\/33098156\/.","journal-title":"Eur J Neurosci [Internet]."},{"key":"2333_CR81","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0006344","volume":"4","author":"A Rahman","year":"2009","unstructured":"Rahman A, Ting K, Cullen KM, Braidy N, Brew BJ, Guillemin GJ. The excitotoxin quinolinic acid induces tau phosphorylation in human neurons. PLoS One. 2009;4:1\u201315.","journal-title":"PLoS One"},{"key":"2333_CR82","doi-asserted-by":"crossref","unstructured":"Fertan E, Stover KRJ, Brant MG, Stafford PM, Kelly B, Diez-Cecilia E, et al. Effects of the novel IDO inhibitor DWG-1036 on the behavior of Male and female 3xTg-AD mice. Front Pharmacol. 2019;10:1044.","DOI":"10.3389\/fphar.2019.01044"},{"key":"2333_CR83","doi-asserted-by":"crossref","unstructured":"Liu Z, Li T, Li P, Wei N, Zhao Z, Liang H, et al. The ambiguous relationship of oxidative stress, tau hyperphosphorylation, and autophagy dysfunction in Alzheimer\u2019s disease. Oxid Med Cell Longev. 2015;2015:352723.","DOI":"10.1155\/2015\/352723"},{"key":"2333_CR84","doi-asserted-by":"publisher","first-page":"495","DOI":"10.3389\/fnins.2017.00495","volume":"11","author":"A Ib\u00e1\u00f1ez-Salazar","year":"2017","unstructured":"Ib\u00e1\u00f1ez-Salazar A, Ba\u00f1uelos-Hern\u00e1ndez B, Rodr\u00edguez-Leyva I, Chi-Ahumada E, Monreal-Escalante E, Jim\u00e9nez-Capdeville ME, et al. Oxidative stress modifies the levels and phosphorylation state of tau protein in human fibroblasts. Front Neurosci. 2017;11:495.","journal-title":"Front Neurosci"},{"key":"2333_CR85","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1016\/j.ajpath.2019.03.006","volume":"189","author":"E Fertan","year":"2019","unstructured":"Fertan E, Rodrigues G, Wheeler RV, Goguen D, Wong AA, James H. et al. Cognitive decline, cerebral-spleen tryptophan metabolism, oxidative stress, cytokine production, and regulation of the Txnip gene in 3xTg-AD mice. Am J Pathol [Internet].2019;189:1435\u201350. https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002944018308496.","journal-title":"Am J Pathol [Internet]."},{"key":"2333_CR86","doi-asserted-by":"crossref","unstructured":"Yoshihara E, Masaki S, Matsuo Y, Chen Z, Tian H, Yodoi J. Thioredoxin\/Txnip: Redoxisome, as a redox switch for the pathogenesis of diseases. Front Immunol. 2013;4:514.","DOI":"10.3389\/fimmu.2013.00514"},{"key":"2333_CR87","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11095-017-2276-2","volume":"35","author":"MAB Melone","year":"2018","unstructured":"Melone MAB, Dato C, Paladino S, Coppola C, Trebini C, Giordana MT, et al. Verapamil inhibits Ser202\/Thr205 phosphorylation of tau by blocking TXNIP\/ROS\/p38 MAPK pathway. Pharm Res. 2018;35:1\u201314.","journal-title":"Pharm Res"},{"key":"2333_CR88","first-page":"A108","volume":"104","author":"AP Worrall","year":"2019","unstructured":"Worrall AP, Gallagher E, Huggard D, Kelly L, Molloy E. GP191 dysregulation of the inflammasome in children with down syndrome. Arch Dis Child [Internet].2019;104:A108\u2013A108. https:\/\/adc.bmj.com\/content\/104\/Suppl_3\/A108.1.","journal-title":"Arch Dis Child [Internet]."},{"key":"2333_CR89","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3389\/fped.2020.00073","volume":"8","author":"D Huggard","year":"2020","unstructured":"Huggard D, Doherty DG, Molloy EJ. Immune dysregulation in children with Down syndrome. Front Pediatr. 2020;8:73.","journal-title":"Front Pediatr"},{"key":"2333_CR90","doi-asserted-by":"crossref","unstructured":"Hulse J, Bhaskar K. Crosstalk between the NLRP3 inflammasome\/ASC speck and amyloid protein aggregates drives disease progression in Alzheimer\u2019s and Parkinson\u2019s disease. Front Mol Neurosci. 2022;15:805169.","DOI":"10.3389\/fnmol.2022.805169"},{"key":"2333_CR91","first-page":"16","volume":"13","author":"T Liang","year":"2022","unstructured":"Liang T, Zhang Y, Wu S, Chen Q, Wang L. The role of NLRP3 inflammasome in Alzheimer\u2019s disease and potential therapeutic targets. Front Pharm [Internet]. 2022;13:16.","journal-title":"Front Pharm [Internet]."},{"key":"2333_CR92","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1111\/j.1600-065X.2011.01046.x","volume":"243","author":"O Gross","year":"2011","unstructured":"Gross O, Thomas CJ, Guarda G, Tschopp J. The inflammasome: an integrated view. Immunol Rev [Internet].2011;243:136\u201351. https:\/\/pubmed.ncbi.nlm.nih.gov\/21884173\/.","journal-title":"Immunol Rev [Internet]."},{"key":"2333_CR93","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/ni.1836","volume":"11","author":"CR Stewart","year":"2010","unstructured":"Stewart CR, Stuart LM, Wilkinson K, van Gils JM, Deng J, Halle A. et al. CD36 ligands promote sterile inflammation through assembly of a toll-like receptor 4 and 6 heterodimer. Nat Immunol [Internet].2010;11:155\u201361. https:\/\/pubmed.ncbi.nlm.nih.gov\/20037584\/.","journal-title":"Nat Immunol [Internet]."},{"key":"2333_CR94","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1038\/ni.2639","volume":"14","author":"FJ Sheedy","year":"2013","unstructured":"Sheedy FJ, Grebe A, Rayner KJ, Kalantari P, Ramkhelawon B, Carpenter SB. et al. CD36 coordinates NLRP3 inflammasome activation by facilitating intracellular nucleation of soluble ligands into particulate ligands in sterile inflammation. Nat Immunol [Internet].2013;14:812\u201320. https:\/\/pubmed.ncbi.nlm.nih.gov\/23812099\/.","journal-title":"Nat Immunol [Internet]."},{"key":"2333_CR95","doi-asserted-by":"publisher","first-page":"939","DOI":"10.3233\/JAD-210268","volume":"83","author":"M van Zeller","year":"2021","unstructured":"van Zeller M, Dias D, Sebasti\u00e3o AM, Valente CA. NLRP3 inflammasome: a starring role in Amyloid-\u03b2- and tau-driven pathological events in Alzheimer\u2019s disease. J Alzheimer\u2019s Dis [Internet]. 2021;83:939.","journal-title":"J Alzheimer\u2019s Dis [Internet]"},{"key":"2333_CR96","doi-asserted-by":"crossref","unstructured":"Nakanishi A, Kaneko N, Takeda H, Sawasaki T, Morikawa S, Zhou W, et al. Amyloid \u03b2 directly interacts with NLRP3 to initiate inflammasome activation: identification of an intrinsic NLRP3 ligand in a cell-free system. Inflamm Regen. 2018;38:27.","DOI":"10.1186\/s41232-018-0085-6"},{"key":"2333_CR97","doi-asserted-by":"crossref","unstructured":"Perluigi M, Butterfield DA. Oxidative stress and Down syndrome: a route toward Alzheimer-like dementia. Curr Gerontol Geriatr Res. 2012;2012:724904.","DOI":"10.1155\/2012\/724904"},{"key":"2333_CR98","doi-asserted-by":"publisher","first-page":"88","DOI":"10.4161\/cam.3.1.7402","volume":"3","author":"A Gella","year":"2009","unstructured":"Gella A, Durany N. Oxidative stress in Alzheimer\u2019s disease. Cell Adh Migr. 2009;3:88\u201393.","journal-title":"Cell Adh Migr"},{"key":"2333_CR99","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1016\/j.bbadis.2013.10.015","volume":"1842","author":"X Wang","year":"2014","unstructured":"Wang X, Wang W, Li L, Perry G, Lee HG, Zhu X. Oxidative stress and mitochondrial dysfunction in Alzheimer\u2019s disease. Biochim Biophys Acta (BBA) - Mol Basis Dis [Internet]. 2014;1842:1240\u20137. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24189435.","journal-title":"Biochim Biophys Acta (BBA) - Mol Basis Dis [Internet]"},{"key":"2333_CR100","doi-asserted-by":"publisher","first-page":"139","DOI":"10.3233\/JAD-190223","volume":"72","author":"Y Wang","year":"2019","unstructured":"Wang Y, Wang Y, Bharti V, Zhou H, Hoi V, Tan H. et al. Upregulation of thioredoxin-interacting protein in brain of amyloid-\u03b2 protein precursor\/presenilin 1 transgenic mice and amyloid-\u03b2 treated neuronal cells. J Alzheimers Dis [Internet].2019;72:139\u201350. https:\/\/pubmed.ncbi.nlm.nih.gov\/31561358\/.","journal-title":"J Alzheimers Dis [Internet]."},{"key":"2333_CR101","doi-asserted-by":"publisher","first-page":"255","DOI":"10.3233\/JAD-180814","volume":"68","author":"L Li","year":"2019","unstructured":"Li L, Ismael S, Nasoohi S, Sakata K, Liao FF, McDonald MP. et al. Thioredoxin-interacting protein (TXNIP) associated NLRP3 inflammasome activation in human Alzheimer\u2019s disease brain. J Alzheimers Dis [Internet].2019;68:255\u201365. https:\/\/pubmed.ncbi.nlm.nih.gov\/30741672\/.","journal-title":"J Alzheimers Dis [Internet]."},{"key":"2333_CR102","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/nature12517","volume":"501","author":"MA Lancaster","year":"2013","unstructured":"Lancaster MA, Renner M, Martin CA, Wenzel D, Bicknell LS, Hurles ME. et al. Cerebral organoids model human brain development and microcephaly. Nature [Internet]. 2013;501:373\u20139. https:\/\/pubmed.ncbi.nlm.nih.gov\/23995685\/.","journal-title":"Nature [Internet]"},{"key":"2333_CR103","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/s41578-021-00279-y","volume":"6","author":"M Hofer","year":"2021","unstructured":"Hofer M, Lutolf MP. Engineering organoids. Nat Rev Mater. 2021;6:402\u201320. https:\/\/www.nature.com\/articles\/s41578-021-00279-y.","journal-title":"Nat Rev Mater"},{"key":"2333_CR104","doi-asserted-by":"crossref","unstructured":"Gatz M, Pedersen NL, Berg S, Johansson B, Johansson K, Mortimer JA, et al. Heritability for Alzheimer\u2019s disease: the study of dementia in Swedish twins. J Gerontol A Biol Sci Med Sci [Internet]. 1997;52. https:\/\/pubmed.ncbi.nlm.nih.gov\/9060980\/.","DOI":"10.1093\/gerona\/52A.2.M117"},{"key":"2333_CR105","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1177\/089198879600900104","volume":"9","author":"JM Swearer","year":"1996","unstructured":"Swearer JM, O\u2019Donnell BF, Ingram SM, Drachman DA. Rate of progression in familial Alzheimer\u2019s disease. J Geriatr Psychiatry Neurol [Internet].1996;9:22\u20135. https:\/\/pubmed.ncbi.nlm.nih.gov\/8679059\/.","journal-title":"J Geriatr Psychiatry Neurol [Internet]."}],"container-title":["Molecular Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41380-023-02333-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-023-02333-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-023-02333-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T09:05:18Z","timestamp":1716455118000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41380-023-02333-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,15]]},"references-count":105,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["2333"],"URL":"https:\/\/doi.org\/10.1038\/s41380-023-02333-3","relation":{},"ISSN":["1359-4184","1476-5578"],"issn-type":[{"value":"1359-4184","type":"print"},{"value":"1476-5578","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,15]]},"assertion":[{"value":"6 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}